These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9616644)

  • 1. Screening for neuroleptic side-effects.
    Marland G; McSherry W
    Nurs Times; 1998 Mar 25-31; 94(12):54-5. PubMed ID: 9616644
    [No Abstract]   [Full Text] [Related]  

  • 2. Nursing the mind. Minimizing adverse drug reactions.
    Vallone DC; Stephanos MJ
    RN; 1990 Nov; 53(11):36-43. PubMed ID: 1980028
    [No Abstract]   [Full Text] [Related]  

  • 3. Extrapyramidal side effects.
    Houltram B; Scanlan M
    Nurs Stand; 2004 Jul 7-13; 18(43):39-41. PubMed ID: 15318651
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current status of our knowledge of the neurotropic side effects of neuroleptic drugs].
    Sabbatini F; Pinessi L; Gentile S; De Mattei M; Portaleone P
    Minerva Psichiatr; 1983; 24(4):145-53. PubMed ID: 6145083
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment scales for tardive dyskinesia.
    Bostrom AC
    J Psychosoc Nurs Ment Health Serv; 1988 Jun; 26(6):9-12. PubMed ID: 2905746
    [No Abstract]   [Full Text] [Related]  

  • 6. Tardive dyskinesia.
    Portnoi VA; Johnson JE
    J Pract Nurs; 1982 Apr; 32(4):26-8. PubMed ID: 6122736
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-induced dyskinesias.
    Rosal-Greif VL
    Am J Nurs; 1982 Jan; 82(1):66-9. PubMed ID: 6119904
    [No Abstract]   [Full Text] [Related]  

  • 8. Does long-acting injectable neuroleptic protect against tardive dyskinesia?
    Goldberg SC; Shenoy RS; Julius D; Hamer RM; Ross B; Minton T; Spiro M
    Psychopharmacol Bull; 1982 Oct; 18(4):177-9. PubMed ID: 6130561
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of the side effects of antipsychotic medication.
    Walker H; MacAulay K
    Nurs Stand; 2005 Jun 15-21; 19(40):41-6. PubMed ID: 15977489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New "atypical" neuroleptics -- the emperor's new clothes?].
    Dose M
    Psychiatr Prax; 2003 Jan; 30(1):1-3. PubMed ID: 12524575
    [No Abstract]   [Full Text] [Related]  

  • 11. No substitute for care.
    Daniels S
    Nurs Stand; 2008 May 21-27; 22(37):28. PubMed ID: 18763656
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of neuroleptic drugs.
    Nurs Stand; 1996 Apr; 10(29):32-3. PubMed ID: 8695528
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychopharmacists' role in neuroleptic therapy. A pharmaceutical care approach.
    Lacro JP; Kodsi AB; Gilbert PL
    J Pharm Technol; 1994; 10(4):164-8. PubMed ID: 10139093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An effective computer-based tardive dyskinesia monitoring system.
    Hammond KW; Snowden M; Risse SC; Adkins TG; O'Brien JJ
    Am J Med Qual; 1995; 10(3):133-7. PubMed ID: 7549594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic-induced movement disorders: deconstructing extrapyramidal symptoms.
    Trosch RM
    J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S266-71. PubMed ID: 15541167
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of the Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) in clinical practice.
    Morrison P; Gaskill D; Meehan T; Lunney P; Lawrence G; Collings P
    Aust N Z J Ment Health Nurs; 2000 Dec; 9(4):166-76. PubMed ID: 11887267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis and nursing care of extrapyramidal reactions caused by antipsychotics in 75 cases].
    Li NP
    Zhonghua Hu Li Za Zhi; 1997 Feb; 32(2):84-6. PubMed ID: 9369564
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk management for extrapyramidal symptoms.
    Glazer WM
    QRB Qual Rev Bull; 1990 Jul; 16(7):270. PubMed ID: 1977115
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia.
    Cortese L; Caligiuri MP; Williams R; Schieldrop P; Manchanda R; Malla A; Harricharan R
    J Clin Psychopharmacol; 2008 Feb; 28(1):69-73. PubMed ID: 18204344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring depression in patients undergoing alpha-interferon and ribavirin therapy for hepatitis C.
    Wright IA
    Gastroenterol Nurs; 2000; 23(6):275-80. PubMed ID: 11854972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.